Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advair vs Salmeterol in COPD Anti-Inflammatory Effect
NCT00346749Phase 4Terminated
- Sponsor
- GSK
- Start
- Dec 2006
- Primary completion
- Jul 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Dec 2006; status: terminated.
02
Drugs
fluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00346749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346749.